Practical guidance for the use of bisphosphonates in osteoporosis.

Bone

Bone Medicine, Cambridge Biomedical Campus, Cambridge, UK. Electronic address:

Published: July 2020

Bisphosphonates are widely used in the treatment of osteoporosis in postmenopausal women and older men. In clinical trials they have been shown to reduce fractures in women with osteoporosis and there is increasing evidence that they are also effective in women with osteopenia, in whom the majority of fractures occur. In addition to their role as initial therapy in individuals at increased risk of fracture, bisphosphonates are used as sequential therapy after treatment with anabolic drugs. There are no head-to head studies to compare the anti-fracture efficacy of different bisphosphonates, but there is limited evidence that zoledronate treatment results in greater increases in BMD than risedronate or alendronate. This, together with the need for less frequent administration of zoledronate, supports its wider use in clinical practice, particularly if longer dosing intervals than those currently recommended are shown to be effective.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2020.115330DOI Listing

Publication Analysis

Top Keywords

practical guidance
4
bisphosphonates
4
guidance bisphosphonates
4
bisphosphonates osteoporosis
4
osteoporosis bisphosphonates
4
bisphosphonates treatment
4
treatment osteoporosis
4
osteoporosis postmenopausal
4
postmenopausal women
4
women older
4

Similar Publications

Early career researchers (ECRs) in nutrition and related fields often wish to approach commercial organisations for possible funding or collaboration in scientific projects and other activities. However, ECRs may experience challenges from their limited experience, lack of understanding of the food industry and concerns about working practices and research integrity. This commentary is oriented toward providing some basic, practical guidance for nutritionist scientists, to help in developing credible, principled and effective working relationships with the food industry.

View Article and Find Full Text PDF

Background: Involving people with lived experience in United Kingdom healthcare courses is a government directive and professional body recommendation, yet involvement remains non-standardised with minimal guidance. Previous literature has largely ignored the experiences of Nurse lecturer's in this work, yet they provide vital resources in promoting, sustaining and developing the involvement of people with lived experience.

Aim: To explore adult nurse lecturers' experiences of working with people with lived experience in two higher educational institution settings.

View Article and Find Full Text PDF

Factors Contributing to Opioid Overprescribing at Surgical Discharge.

J Surg Res

January 2025

Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, Arkansas. Electronic address:

Introduction: Opioids remain the gold standard for treating acute pain, whereas overprescribing occurs regularly in the postoperative setting with little clinical guidance. The objective of this study is to examine whether the length of surgery is an independent risk factor for opioid overprescribing at discharge.

Methods: We conducted a retrospective case-control study to determine if there is an association between the length of surgery and overprescribed opioids.

View Article and Find Full Text PDF

Official development agencies are increasingly supporting civil society lobby and advocacy (L&A) to address poverty and human rights. However, there are challenges in evaluating L&A. As programme objectives are often to change policies or practices in a single institution like a Government Ministry, L&A programmes are often not amenable to large-n impact evaluation methods.

View Article and Find Full Text PDF

Contrast media, including iodinated contrast media and gadolinium-based contrast agents, are commonly administered pharmaceuticals with excellent safety profiles. However, a minority of the population may experience a hypersensitivity reaction following intravenous administration. Hypersensitivity reactions can be immediate or delayed, and range from mild, such as urticaria, to severe, including anaphylaxis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!